NPI: 1063880854 · SAINT CLOUD, FL 34769 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/10/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/10/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,682 | $1.99M |
| 2019 | 27,983 | $2.77M |
| 2020 | 28,930 | $3.81M |
| 2021 | 19,566 | $1.30M |
| 2022 | 5,116 | $501K |
| 2023 | 5,677 | $166K |
| 2024 | 3,665 | $133K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,732 | 1,272 | $3.32M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 31,364 | 1,857 | $3.12M |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,940 | 1,071 | $1.63M |
| J1756 | Injection, iron sucrose, 1 mg | 11,278 | 1,113 | $949K |
| A4657 | Syringe, with or without needle, each | 4,890 | 1,569 | $740K |
| 85041 | 1,572 | 894 | $173K | |
| 85048 | 1,483 | 842 | $173K | |
| 83970 | 1,385 | 792 | $165K | |
| 83550 | 990 | 535 | $109K | |
| 83540 | 990 | 535 | $109K | |
| 82728 | 903 | 493 | $101K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 629 | 277 | $44K |
| 82108 | 111 | 67 | $16K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 58 | 35 | $13K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 294 | 108 | $6K |